
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Robot-assisted surgery: Hansen Medical drums up $35m private placement
Hansen Medical said that it drummed up $35 million for its robot-assisted surgery devices from a syndicate of investors that includes its founder, a director and a pair of hedge funds.
Mountain View, Calif.-based Hansen said the funding round, which includes convertible stock and warrants worth another $52.5 million, could eventually reach the $87.5 million mark if the warrants are exercised. Read more
2. Zimmer releases post-Biomet merger numbers
Zimmer said its pending, $13.35 billion combination with Biomet will result in an entity that throws off annual profits of nearly $850 million on sales of about $8 billion.
Warsaw, Ind.-based Zimmer released a pro-forma financial estimate of the post-merger company, projecting profits of $849.4 million, or $4.16 per share, on sales of $7.95 billion. Read more
1. Diabetes: Valeritas sets terms for $75m IPO
Valeritas set the terms for its forthcoming initial public offering, saying it plans to put up 5 million shares at $14 to $16 each.
At the midpoint of the range, the IPO would fetch $75 million for Bridgewater, N.J.-based Valeritas, which plans to list on the NASDAQ exchange under the “VLRX” symbol. Read more